MLRTX
Price
$10.83
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RGEBX
Price
$73.96
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

MLRTX vs RGEBX

Header iconMLRTX vs RGEBX Comparison
Open Charts MLRTX vs RGEBXBanner chart's image
NYLI Winslow Large Cap Growth Class R2
Price$10.83
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.96
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MLRTX vs RGEBX Comparison Chart
Loading...
VS
MLRTX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLRTX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. MLRTX (14.3B). RGEBX pays higher dividends than MLRTX: RGEBX (0.16) vs MLRTX (0.00). MLRTX was incepted earlier than RGEBX: MLRTX (19 years) vs RGEBX (10 years). MLRTX is a more actively managed with annual turnover of: 81.00 vs. RGEBX (31.00). MLRTX has a lower initial minimum investment than RGEBX: MLRTX (0) vs RGEBX (250). RGEBX (22.86) and MLRTX (22.36) have marching annual gain over last year. RGEBX return over 5 years is better than : 47.60 vs. MLRTX (11.63).
MLRTXRGEBXMLRTX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years10 years-
Gain YTD19.59218.896104%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets14.3B284B5%
Annual Yield % from dividends0.000.16-
Returns for 1 year22.3622.8698%
Returns for 3 years-26.36-4.80550%
Returns for 5 years11.6347.6024%
Returns for 10 years-1.5856.25-3%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics